Morgan Stanley
MBOT icon

Morgan Stanley’s Microbot Medical MBOT Stock Holding History

Morgan Stanley’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$189K Buy
78,504
+9,532
+14% +$21.3K ﹤0.01% 5898
2025
Q4 		$138K Buy
68,972
+61,129
+779% +$145K ﹤0.01% 6071
2025
Q3 		$23.9K Sell
7,843
-149,927
-95% -$468K ﹤0.01% 6631
2025
Q2 		$398K Buy
157,770
+136,757
+651% +$327K ﹤0.01% 5565
2025
Q1 		$31.7K Buy
21,013
+20,001
+1,976% +$35.4K ﹤0.01% 6420
2024
Q4 		$1.13K Hold
1,012
– – ﹤0.01% 7257
2024
Q3 		$905 Buy
1,012
+1
+0.1% +$1 ﹤0.01% 7231
2024
Q2 		$1.03K Sell
1,011
-201
-17% -$207 ﹤0.01% 7151
2024
Q1 		$1.49K Sell
1,212
-64,864
-98% -$82.3K ﹤0.01% 7116
2023
Q4 		$108K Buy
66,076
+26,039
+65% +$34.7K ﹤0.01% 6136
2023
Q3 		$55.7K Sell
40,037
-1,152
-3% -$2.5K ﹤0.01% 6122
2023
Q2 		$112K Buy
41,189
+2,100
+5% +$4.21K ﹤0.01% 5900
2023
Q1 		$81.3K Buy
39,089
+2,751
+8% +$8.14K ﹤0.01% 6094
2022
Q4 		$109K Sell
36,338
-1,550
-4% -$6.43K ﹤0.01% 5938
2022
Q3 		$181K Hold
37,888
– – ﹤0.01% 5772
2022
Q2 		$195K Sell
37,888
-383
-1% -$2.13K ﹤0.01% 5914
2022
Q1 		$240K Buy
38,271
+3,486
+10% +$20.4K ﹤0.01% 5817
2021
Q4 		$261K Buy
34,785
+15,347
+79% +$98.9K ﹤0.01% 5920
2021
Q3 		$137K Buy
19,438
+15,934
+455% +$116K ﹤0.01% 6195
2021
Q2 		$28K Buy
3,504
+1,492
+74% +$11.3K ﹤0.01% 6888
2021
Q1 		$17K Sell
2,012
-999
-33% -$8.59K ﹤0.01% 6780
2020
Q4 		$21K Sell
3,011
-204
-6% -$1.53K ﹤0.01% 6421
2020
Q3 		$25K Sell
3,215
-1,448
-31% -$10.2K ﹤0.01% 5977
2020
Q2 		$32K Sell
4,663
-13,858
-75% -$93.8K ﹤0.01% 5848
2020
Q1 		$103K Buy
18,521
+14,434
+353% +$126K ﹤0.01% 5172
2019
Q4 		$42K Sell
4,087
-286
-7% -$1.68K ﹤0.01% 5905
2019
Q3 		$23K Sell
4,373
-1,943
-31% -$11.4K ﹤0.01% 5964
2019
Q2 		$32K Buy
6,316
+2,748
+77% +$18.2K ﹤0.01% 5779
2019
Q1 		$28K Buy
3,568
+2,965
+492% +$23.1K ﹤0.01% 5904
2018
Q4 		$1K Buy
603
+531
+738% +$2.01K ﹤0.01% 6507
2018
Q3 		$1K Sell
72
-32
-31% -$276 ﹤0.01% 6632
2018
Q2 		$1K Buy
104
+15
+17% +$183 ﹤0.01% 6593
2018
Q1 		$0 Sell
89
-96
-52% -$1.3K ﹤0.01% 6661
2017
Q4 		$3K Buy
185
+122
+194% +$2.07K ﹤0.01% 6402
2017
Q3 		$1K Sell
63
-430
-87% -$7.58K ﹤0.01% 6453
2017
Q2 		$11K Sell
493
-160
-25% -$8.83K ﹤0.01% 6219
2017
Q1 		$58K Buy
653
+643
+6,430% +$56.5K ﹤0.01% 5788
2016
Q4 		$1K Buy
+10
New +$1.26K ﹤0.01% 6444
2016
Q3 		– Sell
-2
Closed -$261 – 6535
2016
Q2 		$0 Buy
+2
New +$577 ﹤0.01% 6591
2016
Q1 		– Sell
-1
Closed -$528 – 6652
2015
Q4 		$1K Sell
1
-99
-99% -$72.7K ﹤0.01% 6569
2015
Q3 		$65K Sell
100
-14
-12% -$10.6K ﹤0.01% 5622
2015
Q2 		$99K Buy
114
+103
+936% +$121K ﹤0.01% 5594
2015
Q1 		$19K Sell
11
-1
-8% -$1.79K ﹤0.01% 6065
2014
Q4 		$17K Hold
12
– – ﹤0.01% 6094
2014
Q3 		$24K Sell
12
-1
-8% -$2.64K ﹤0.01% 5951
2014
Q2 		$42K Sell
13
-45
-78% -$104K ﹤0.01% 5821
2014
Q1 		$125K Buy
58
+52
+867% +$124K ﹤0.01% 5348
2013
Q4 		$11K Buy
+6
New +$12.7K ﹤0.01% 6022

Other funds holding MBOT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Morgan Stanley's MBOT Position: Q1 2026 in Review

Morgan Stanley increased its Microbot Medical (MBOT) stake by 14% in Q1 2026, buying an estimated $21.3K and bringing the position to 78,504 shares worth $189K. The position accounts for ﹤0.01% of the portfolio, ranked #5898.

Morgan Stanley first reported a position in MBOT in Q4 2013 and has held it in 48 quarters since. The position peaked at $398K in Q2 2025. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

  • Morgan Stanley held 78,504 shares of Microbot Medical worth $189K as of Q1 2026.
  • Morgan Stanley bought 9,532 Microbot Medical shares in Q1 2026, an estimated $21.3K.
  • Microbot Medical made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #5898 holding.
  • Morgan Stanley first reported a position in Microbot Medical in Q4 2013 and has held it in 48 quarters since.
  • Morgan Stanley's Microbot Medical position peaked at $398K in Q2 2025.
  • 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.